Clinical trials for Alzheimer’s treatment face global shortage of participants
The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer's Disease International warns.
We haven't written up this one. Japan Times has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.